Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
The First Affiliated Hospital with Nanjing Medical University
258 participants
Sep 17, 2023
OBSERVATIONAL
Conditions
Summary
Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.
Eligibility
Inclusion Criteria1
- patients with at least one coronary CTO lesion at our hospital in between January 2011 and December 2017
Exclusion Criteria4
- (1) patients with ST-segment elevation myocardial infarction (STEMI)
- (2)a history of coronary artery bypass grafting (CABG)
- (3) cardiogenic shock
- (4) malignant tumor. Patients were referred for PCI based on CTO-related symptoms or evidence of viability, or corresponding ischemia in the area of the CTO artery.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
successful percutaneous coronary intervention (PCI) in Coronary chronic total occlusions (CTOs) patients
optimal medical therapy (OMT) in CTO patients, such as aspirin 1td, ACEI/ARB 1td, β blocker 1td, statin 1td.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06542653